Randomized Trial of Long-Acting Sustained-Release Naltrexone Implant vs Oral Naltrexone or Placebo for Preventing Relapse to Opioid Dependence

類似資料

• ANHEDONIA, DEPRESSION, ANXIETY, AND CRAVING FOR OPIATES IN OPIATE DEPENDENT PATIENTS STABILIZED ON ORAL NALTREXONE OR AN EXTENDED RELEASE NALTREXONE IMPLANT
  著者:: Krupitsky, Evgeny, 等
  出版事項: (2016)
• Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia
  著者:: Krupitsky, Evgeny, 等
  出版事項: (2013)
• Slow Release Naltrexone Implant vs Oral Naltrexone for Improving Treatment Outcomes in Opioid Addicted Participants with HIV: A Placebo-Controlled Randomised Trial
  著者:: Krupitsky, Evgeny, 等
  出版事項: (2019)
• Use of Naltrexone to Treat Opioid Addiction in a Country in Which Methadone and Buprenorphine Are Not Available
  著者:: Krupitsky, Evgeny, 等
  出版事項: (2010)
• Depression, Substance Use, Viral Load, and CD4+ Count among Patients who continued or left Antiretroviral Therapy for HIV in St. Petersburg, Russian Federation
  著者:: Pecoraro, Anna, 等
  出版事項: (2014)